Modified gemcitabine, S-1, and leucovorin combination for patients with newly diagnosed locally advanced or metastatic pancreatic adenocarcinoma: A multi-center retrospective study in Taiwan

• Chia-Yu Chen,

  Roles Data curation, Formal analysis, Investigation

  Affiliation Division of Hematology and Oncology, Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan

  ⨯
• Shih-Hsin Liang,

  Roles Data curation, Formal analysis, Investigation, Writing – original draft

  Affiliations Division of Hematology and Oncology, Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan, Department of Internal Medicine, Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Chia-Yi, Taiwan

  ⨯
• Yung-Yeh Su,

  Roles Data curation, Formal analysis, Investigation, Writing – original draft

  Affiliations National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan, Division of Hematology and Oncology, Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan

  ⨯
• Nai-Jung Chiang,

  Roles Data curation, Formal analysis, Writing – original draft

  Affiliations National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan, Division of Hematology and Oncology, Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan

  ⨯
• Hui-Ching Wang,

  Roles Data curation, Investigation, Writing – original draft

  Affiliation Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan

  ⨯
• Chang-Fang Chiu,

  Roles Conceptualization, Funding acquisition, Resources, Writing – review & editing

  Affiliations Division of Hematology and Oncology, Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan, College of Medicine, School of Medicine, China Medical University, Taichung, Taiwan, Cancer Center, China Medical University Hospital, Taichung, Taiwan

  ⨯
• Li-Tzong Chen ,

  Contributed equally to this work with: Li-Tzong Chen, Li-Yuan Bai

  Roles Conceptualization, Formal analysis, Resources, Writing – review & editing

  * E-mail: leochen@nhri.edu.tw (L-TC); lybai6@gmail.com (L-YB)

  Affiliations National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan, Division of Hematology and Oncology, Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan

  ⨯
• Li-Yuan Bai

  Contributed equally to this work with: Li-Tzong Chen, Li-Yuan Bai

  Roles Conceptualization, Funding acquisition, Investigation, Writing – original draft

  * E-mail: leochen@nhri.edu.tw (L-TC); lybai6@gmail.com (L-YB)

  Affiliations Division of Hematology and Oncology, Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan, College of Medicine, School of Medicine, China Medical University, Taichung, Taiwan

  https://orcid.org/0000-0001-7739-4077

  ⨯